Related Experiment Video
Updated: Aug 23, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
[Hepatitis C virus infection and clinical outcome of kidney transplantation]
Li-xin Yu1, Zhi-peng Wang, Shao-jie Fu
1Department of Kidney Transplantation, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China. liuxy@fimmu.com
Insights
Hepatitis C virus (HCV) infection significantly reduces long-term survival after kidney transplantation. HCV infection should be considered a relative contraindication for renal transplantation due to increased mortality risk.
Area of Science:
- Nephrology
- Hepatology
- Transplantation Immunology
Context:
- Kidney transplantation is a life-saving procedure for end-stage renal disease.
- Hepatitis C virus (HCV) infection is a common comorbidity in kidney transplant candidates.
- The impact of HCV on kidney transplant outcomes requires further elucidation.
Purpose:
- To investigate the influence of hepatitis C virus (HCV) infection on clinical outcomes following kidney transplantation.
- To compare recipient and graft survival, rejection rates, and causes of death between HCV-infected and non-infected kidney transplant recipients.
Summary:
- A study compared 86 HCV-infected kidney transplant recipients with 86 non-infected recipients.
- HCV-infected recipients showed significantly lower 5-year survival (74.4%) compared to non-infected recipients (87.2%).
- While short-term survival and rejection rates were comparable, hepatic disease was the primary cause of mortality in HCV-infected patients.
Impact:
- HCV infection negatively impacts long-term survival in kidney transplant recipients.
- These findings suggest HCV infection may be a relative contraindication for kidney transplantation.
- Consideration of HCV status is crucial for optimizing kidney transplant outcomes and patient survival.
Objective:
To study the influence of hepatitis C virus (HCV) infection on the clinical outcome of kidney transplantation.
Methods:
The recipient/graft survival, the incidence of acute/chronic rejection and cause of death in 86 HCV-infected recipients of renal transplantation were compared with those in another 86 recipients without HCV infection.
Results:
HCV-infected recipients had significantly shorter 5-year survival (74.4%) than those without HCV infection (87.2%, P<0.01). The 1-year (94.2%/90.7% vs 96.8%/96.0%) and 3-year recipient/graft survival rates (88.4%/79.1% vs 90.7%/87.2%), the incidence of acute/chronic rejection (31.3% vs 21.2%, and 12.5% vs 6.5%) and the 5-year graft survival (73.3%/81.4%) were comparable between the two groups (P>0.05). Hepatic disease was identified as the primary cause of mortality.
Conclusions:
HCV infection may affect the long-term survival of the recipients with kidney transplantation, and therefore should be considered as a relative contraindication of kidney transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Hepatitis
Kidney Transplant III: Nursing Management
Viral Hepatitis I: Introduction